Aberrant expression of cytokeratin 7 in perivenular hepatocytes correlates with a cholestatic chemistry profile in patients with heart failure

Modern Pathology

Volumn 23, Issue 12, 2010, Pages 1650-1656

  Pai, Rish K ^a   Hart, John A ^a,b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

cytokeratin 7; ductular reaction; heart failure; hepatocytes; sinusoidal dilatation; venous outflow obstruction

Indexed keywords

BILIRUBIN; CYTOKERATIN 7;

ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; LIVER HISTOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CHOLESTASIS; FEMALE; HEART FAILURE; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-7; LIVER; MALE;

EID: 78649700468     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.175     Document Type: Article

References (16)

1. Wanless IR. Vascular Disorders. In: Alastair D Burt, Bernard C Portmann, Linda D Ferrell (eds). MacSween's Pathology of the Liver, 5th Edn. Churchill Livingston Elsevier: Philadelphia, PA, 2007, pp 613-648.
2. Naschitz JE, Slobodin G, Lewis RJ, et al. Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 2000;140:111-120.
3. Wanless IR, Liu JJ, Butany J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology 1995;21:1232-1237.
4. Kakar S, Batts KP, Poterucha JJ, et al. Histologic changes mimicking biliary disease in liver biopsies with venous outflow impairment. Mod Pathol 2004;17: 874-878.
5. Kajikawa K, Kakihara S. An electron microscope study of the basement membrane of proliferated bile duc-tules. Exp Mol Pathol 1969;11:17-27.
6. Yabushita K, Yamamoto K, Ibuki N, et al. Aberrant expression of cytokeratin 7 as a histological marker of progression in primary biliary cirrhosis. Liver 2001;21:50-55.
7. Van Eyken P, Sciot R, Desmet VJ. A cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express 'bile duct-type' cytokeratins. Histopathology 1989;15:125-135.
8. Tan J, Hytiroglou P, Wieczorek R, et al. Immunohisto-chemical evidence for hepatic progenitor cells in liver diseases. Liver 2002;22:365-373.
9. Washington K. Update on post-liver transplantation infections, malignancies, and surgical complications. Adv Anat Pathol 2005;12:221-226.
10. Chandra R, Kapoor D, Tharakan A, et al. Portal biliopathy. J Gastroenterol Hepatol 2001;16:1086-1092.
11. Clouston AD, Powell EE, Walsh MJ, et al. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 2005;41:809-818.
12. Richardson MM, Jonsson JR, Powell EE, et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 2007;133:80-90.
13. Rygiel KA, Robertson H, Marshall HL, et al. Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest 2008;88:112-123.
14. Gieling RG, Burt AD, Mann DA. Fibrosis and cirrhosis reversibility- molecular mechanisms. Clin Liver Dis 2008;12:915-937, xi.
15. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-218.
16. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-1669.